Found: 7
Select item for more details and to access through your institution.
Atransgenic mouse line for assaying tissue-specific changes in endoplasmic reticulum proteostasis.
- Published in:
- Transgenic Research, 2023, v. 32, n. 3, p. 209, doi. 10.1007/s11248-023-00349-7
- By:
- Publication type:
- Article
A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 691, p. 1, doi. 10.1126/scitranslmed.abq2915
- By:
- Publication type:
- Article
Effects of Withdrawal from Cocaine Self- Administration on Rat Orbitofrontal Cortex Parvalbumin Neurons Expressing Cre recombinase: Sex-Dependent Changes in Neuronal Function and Unaltered Serotonin Signaling.
- Published in:
- eNeuro, 2021, v. 8, n. 4, p. 1, doi. 10.1523/ENEURO.0017-21.2021
- By:
- Publication type:
- Article
Prolyl Oligopeptidase Regulates Dopamine Transporter Oligomerization and Phosphorylation in a PKC- and ERK-Independent Manner.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 1777, doi. 10.3390/ijms22041777
- By:
- Publication type:
- Article
Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-54034-z
- By:
- Publication type:
- Article
Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse.
- Published in:
- Molecular Neurobiology, 2018, v. 55, n. 1, p. 470, doi. 10.1007/s12035-016-0339-8
- By:
- Publication type:
- Article
Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
- Published in:
- Journal of Neuroscience, 2016, v. 36, n. 49, p. 12485, doi. 10.1523/JNEUROSCI.2309-16.2016
- By:
- Publication type:
- Article